ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Generate Biomedicines
20.02
+2.30
12.98%
成交量：
345.71萬
成交額：
7,155.42萬
市值：
25.66億
市盈率：
-6.11
高：
22.67
開：
17.67
低：
17.39
收：
17.72
52周最高：
22.67
52周最低：
11.00
股本：
1.28億
流通股本：
6,028.82萬
量比：
4.40
換手率：
5.73%
股息：
- -
股息率：
- -
每股收益(TTM):
-3.2762
每股收益(LYR):
-4.9816
淨資產收益率：
-81.72%
總資產收益率：
-34.63%
市淨率：
5.63
市盈率(LYR):
-4.02
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
Generate Biomedicines
交易所：
NASDAQ
成立時間：
2018
員工人數：
312
公司地址：
101 South Street,Suite 900,Somerville,Massachusetts,United States
官網：
http://www.generatebiomedicines.com
郵編：
02143
電話：
(888) 469-0055
傳真：
- -
簡介：
Generate Biomedicines, Inc.於2018年8月根據特拉華州法律成立。作為一家臨床階段的生成生物學公司，該公司首創了名為Generate Platform的人工智能驅動的生物技術平台，該平台將計算模型與可擴展的生物硬件相結合，以設計和開發新型治療性蛋白質。其最先進的候選藥物GB-0895是一種計算工程抗TSLP單克隆抗體，目前正處於嚴重哮喘的關鍵3期試驗中。該平台的能力已通過在2026年將另外兩個腫瘤候選藥物推向1期試驗而得到進一步證明。
董事
名稱
職位
Michael Nally
Chief Executive Officer and Director
Noubar B. Afeyan
Chairperson of the Board
Frances H. Arnold
Director
Jane Mendillo
Director
Marsha H. Fanucci
Director
Nancy A. Simonian
Director
Paul Parker
Director
Rupert Vessey
Director
Stéphane Bancel
Director
股東
名稱
職位
Michael Nally
Chief Executive Officer and Director
Jason Silvers
Chief Financial Officer and President
Aarif Khakoo
Chief Scientific Officer
Beth Grous
Chief People Officer
Gevorg Grigoryan
Chief Technology Officer and Co-Founder
Laurie Lee
Chief Medical Officer
Sean Martin
Chief Legal Officer and General Counsel
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/GENB/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","market":"US","secType":"STK","nameCN":"Generate Biomedicines","latestPrice":20.02,"timestamp":1787679291351,"preClose":17.72,"halted":0,"volume":3457131,"delay":0,"changeRate":0.12979683972911968,"floatShares":60288200,"shares":128192484,"eps":-3.27625,"marketStatus":"交易中","change":2.3,"latestTime":"08-25 13:34:52 EDT","open":17.67,"high":22.6699,"low":17.39,"amount":71554210.87167,"amplitude":0.297963,"askPrice":20.1,"askSize":1,"bidPrice":20.02,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.27625,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1772168400000,"exchange":"NASDAQ","adjPreClose":17.72,"preHourTrading":{"tag":"盘前","latestPrice":17.75,"preClose":17.72,"latestTime":"09:29 EDT","volume":2884,"amount":50582.089543999995,"timestamp":1787664599999,"change":0.03,"changeRate":0.001693,"amplitude":0.02991},"postHourTrading":{"tag":"盘后","latestPrice":17.62,"preClose":17.72,"latestTime":"19:57 EDT","volume":26241,"amount":464998.0479,"timestamp":1787615867853,"change":-0.1,"changeRate":-0.005643,"amplitude":0.030096},"volumeRatio":4.398557},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","floatShares":60288200,"roa":"-34.63%","roe":"-81.72%","lyrEps":-4.981642,"volumeRatio":4.398557,"shares":128192484,"dividePrice":0,"high":22.6699,"amplitude":0.297963,"preClose":17.72,"low":17.39,"week52Low":11,"pbRate":"5.63","psRate":"96.91","week52High":22.6699,"institutionHeld":0,"latestPrice":20.02,"committee":0.980198,"eps":-3.27625,"divideRate":0,"volume":3457131,"delay":0,"ttmEps":-3.27625,"open":17.67,"prevYearClose":16,"prevWeekClose":16.12,"prevMonthClose":14,"prevQuarterClose":16.87,"fiveDayClose":16.08,"twentyDayClose":13.14,"sixtyDayClose":13.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GENB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"GENB","fiscalQuarterEnding":"2026/06","expectedEps":-0.48,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-05-07","symbol":"GENB","fiscalQuarterEnding":"2026/03","expectedEps":-0.48,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GENB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1782532800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GENB","date":"2026-08-24","current":-6.315147,"percent":0.181818,"low":-10.037721,"twenty":-8.631423,"median":-7.947852,"eighty":-7.52311,"high":-6.883628,"avg":-8.109,"sd":0.705116,"marketCap":2069041268},"quantilePoints":[{"date":"2026-02-27","current":-10.037721,"twenty":-10.037721,"median":-10.037721,"eighty":-10.037721,"marketCap":2039203216},{"date":"2026-03-06","current":-7.810602,"twenty":-7.936073,"median":-7.722772,"eighty":-7.484376,"marketCap":1586755002},{"date":"2026-03-13","current":-8.331309,"twenty":-7.979988,"median":-7.660036,"eighty":-7.484376,"marketCap":1692538669},{"date":"2026-03-20","current":-7.710225,"twenty":-7.979988,"median":-7.68513,"eighty":-7.484376,"marketCap":1566362970},{"date":"2026-03-27","current":-8.061545,"twenty":-7.979988,"median":-7.697677,"eighty":-7.484376,"marketCap":1637735082},{"date":"2026-04-02","current":-8.350129,"twenty":-7.996299,"median":-7.697677,"eighty":-7.419131,"marketCap":1696362175},{"date":"2026-04-10","current":-7.233433,"twenty":-7.996299,"median":-7.647489,"eighty":-7.419131,"marketCap":1469500817},{"date":"2026-04-17","current":-7.910979,"twenty":-8.036451,"median":-7.697677,"eighty":-7.419131,"marketCap":1607147034},{"date":"2026-04-24","current":-8.067818,"twenty":-8.0628,"median":-7.732183,"eighty":-7.42164,"marketCap":1639009584},{"date":"2026-05-01","current":-7.923526,"twenty":-8.036451,"median":-7.810602,"eighty":-7.471829,"marketCap":1609696038},{"date":"2026-05-08","current":-8.522653,"twenty":-8.180743,"median":-7.816876,"eighty":-7.489394,"marketCap":1731410980},{"date":"2026-05-15","current":-8.844872,"twenty":-8.266063,"median":-7.84197,"eighty":-7.500687,"marketCap":1971654609},{"date":"2026-05-22","current":-8.039526,"twenty":-8.266063,"median":-7.83256,"eighty":-7.486839,"marketCap":1792130926},{"date":"2026-05-29","current":-7.527711,"twenty":-8.282375,"median":-7.816876,"eighty":-7.489371,"marketCap":1678039615},{"date":"2026-06-05","current":-8.453579,"twenty":-8.282375,"median":-7.810602,"eighty":-7.474106,"marketCap":1884429514},{"date":"2026-06-12","current":-7.435699,"twenty":-8.229473,"median":-7.788352,"eighty":-7.435629,"marketCap":1657528818},{"date":"2026-06-18","current":-7.976268,"twenty":-8.211907,"median":-7.788092,"eighty":-7.435594,"marketCap":1778029753},{"date":"2026-06-26","current":-9.442705,"twenty":-8.343203,"median":-7.810602,"eighty":-7.4449,"marketCap":2104920587},{"date":"2026-07-02","current":-9.488711,"twenty":-8.508838,"median":-7.810602,"eighty":-7.463837,"marketCap":2115175986},{"date":"2026-07-10","current":-9.040154,"twenty":-8.869967,"median":-7.84197,"eighty":-7.484992,"marketCap":2015185848},{"date":"2026-07-17","current":-7.855502,"twenty":-8.85402,"median":-7.855502,"eighty":-7.488094,"marketCap":1751109331},{"date":"2026-07-24","current":-7.953265,"twenty":-8.801131,"median":-7.883241,"eighty":-7.493159,"marketCap":1772902053},{"date":"2026-07-31","current":-8.06828,"twenty":-8.626167,"median":-7.861253,"eighty":-7.503197,"marketCap":1798540550},{"date":"2026-08-07","current":-7.489636,"twenty":-8.522653,"median":-7.910979,"eighty":-7.503197,"marketCap":1780593602},{"date":"2026-08-14","current":-8.114449,"twenty":-8.453579,"median":-7.917253,"eighty":-7.52196,"marketCap":1929137113},{"date":"2026-08-21","current":-8.632737,"twenty":-8.626167,"median":-7.947085,"eighty":-7.52196,"marketCap":2052355451},{"date":"2026-08-24","current":-8.702922,"twenty":-8.631423,"median":-7.947852,"eighty":-7.52311,"marketCap":2069041268}],"updateTime":1787670784505},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":659065371,"yearFounded":2018,"employeeNum":312,"address":"101 South Street,Suite 900,Somerville,Massachusetts,United States","zipCode":"02143","officePhone":"(888) 469-0055","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.generatebiomedicines.com","stockEarnings":[{"period":"1week","weight":0.1294},{"period":"1month","weight":0.3224},{"period":"3month","weight":0.3283},{"period":"6month","weight":0.1075},{"period":"ytd","weight":0.1075}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.1831},{"period":"ytd","weight":0.1196}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Generate Biomedicines, Inc.於2018年8月根據特拉華州法律成立。作為一家臨床階段的生成生物學公司，該公司首創了名為Generate Platform的人工智能驅動的生物技術平台，該平台將計算模型與可擴展的生物硬件相結合，以設計和開發新型治療性蛋白質。其最先進的候選藥物GB-0895是一種計算工程抗TSLP單克隆抗體，目前正處於嚴重哮喘的關鍵3期試驗中。該平台的能力已通過在2026年將另外兩個腫瘤候選藥物推向1期試驗而得到進一步證明。","exchange":"NASDAQ","name":"Generate Biomedicines","nameEN":"Generate Biomedicines"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":{"directors":[{"name":"Michael Nally","position":"Chief Executive Officer and Director"},{"name":"Noubar B. Afeyan","position":"Chairperson of the Board"},{"name":"Frances H. Arnold","position":"Director"},{"name":"Jane Mendillo","position":"Director"},{"name":"Marsha H. Fanucci","position":"Director"},{"name":"Nancy A. Simonian","position":"Director"},{"name":"Paul Parker","position":"Director"},{"name":"Rupert Vessey","position":"Director"},{"name":"Stéphane Bancel","position":"Director"}],"executives":[{"name":"Michael Nally","position":"Chief Executive Officer and Director"},{"name":"Jason Silvers","position":"Chief Financial Officer and President"},{"name":"Aarif Khakoo","position":"Chief Scientific Officer"},{"name":"Beth Grous","position":"Chief People Officer"},{"name":"Gevorg Grigoryan","position":"Chief Technology Officer and Co-Founder"},{"name":"Laurie Lee","position":"Chief Medical Officer"},{"name":"Sean Martin","position":"Chief Legal Officer and General Counsel"}]}}}